Excessive alcohol consumption is a significant public health concern, responsible for approximately 6% of all deaths and ...

Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated ...

Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

BioHarvest Sciences Inc. (NASDAQ:BHST) published ‘in vitro' test results for its new olive cell compound, which can reduce ...

Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting approximately 30% of the population.

Ready to save your liver? Transcription factors are paving the way for metabolic dysfunction-associated fatty liver disease ...

A fatty liver is the most common. Dr Sudeep Khanna, senior consultant, gastroenterology, Indraprastha Apollo Hospitals, ...